Profil
John Jacobsen worked as a Senior Director-Medicinal Chemistry at Theravance Biopharma, Inc. from 1998 to 2015.
He then worked as the Chief Scientific Officer at DiCE Therapeutics, Inc. from 2021 to 2023.
Prior to his career, he earned an undergraduate degree from Harvard College and a doctorate from the University of California, Berkeley.
Anciens postes connus de John Jacobsen
| Sociétés | Poste | Fin |
|---|---|---|
| DICE THER | Chief Tech/Sci/R&D Officer | 09/08/2023 |
| THERAVANCE BIOPHARMA, INC. | Corporate Officer/Principal | 01/10/2015 |
Formation de John Jacobsen
| University of California, Berkeley | Doctorate Degree |
| Harvard College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| THERAVANCE BIOPHARMA, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
DICE Therapeutics, Inc.
 DICE Therapeutics, Inc. BiotechnologyHealth Technology DiCE Therapeutics, Inc. is a biopharmaceutical company, which designs and develops a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. The company was founded by J. Kevin Judice on August 14, 2013 and is headquartered in South San Francisco, CA. | Health Technology |
